The US Food and Drug Administration (FDA) last week authorized KalVista Pharmaceutical’s Ekterly for the treatment of acute ...

The Russian nano and pharmaceutical company Rusnano will seek to overturn the High Court of England and Wales's permission to forcefully sell the assets of the England-based subsidiary - Ascension ...

Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...

A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...

Major pharmaceutical companies – including Eli Lilly (NYSE: LLY), Pfizer (NYSE: PFE) and Merck & Co (NYSE: MRK) - are ramping up manufacturing investments in the USA to navigate the evolving trade ...

Positive top-line results from the Phase III EMERGENT-4 and EMERGENT-5 open-label trials evaluating the long-term efficacy, safety, and tolerability of Cobenfy (xanomeline and trospium chloride) in ...

Ireland-based biopharma Jazz Pharmaceuticals has been called out for a couple of indiscretions by The Prescription Medicines Code of Practice Authority (PMCPA), which was established by the ...

CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...

US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...

At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French ...

The National Institute for Health and Care Excellence (NICE) has published final guidance recommending Eli Lilly’s Omvoh ...

California-based Renasant Bio announced its launch to advance next-generation disease-modifying treatments for autosomal ...